{
    "root": "a3c6770a-d279-4ea9-b8ed-5484be18121e",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Lactated Ringers",
    "value": "20250304",
    "ingredients": [
        {
            "name": "SODIUM CHLORIDE",
            "code": "451W47IQ8X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_26710"
        },
        {
            "name": "SODIUM LACTATE",
            "code": "TU7HW0W0QT",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_75228"
        },
        {
            "name": "POTASSIUM CHLORIDE",
            "code": "660YQ98I10",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32588"
        },
        {
            "name": "CALCIUM CHLORIDE",
            "code": "M4I0D6VV5M",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17996"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        }
    ],
    "indications": {
        "text": "lactated ringer \u2019 injection , usp indicated source water electrolytes alkalinizing agent .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "important preparation instructions \u2022lactated ringer \u2019 injection , usp intended intravenous using sterile equipment . \u2022prior infusion , visually inspect solution particulate matter discoloration . solution clear , precipitates . administer unless solution clear , container undamaged . \u2022to reduce risk air embolism , adhere following preparation instructions lactated ringer \u2019 injection , usp : ouse non-vented infusion set close vent vented set . ouse dedicated line without connections ( connect flexible containers series ) . othe pressure infusion recommended method increase flow rates . however , pressure infusion required , ensure air within bag fully evacuated prior initiation infusion . oif using pumping device administer lactated ringer \u2019 injection , turn pump container empty . \u2022do administer lactated ringer \u2019 injection , usp simultaneously citrate anticoagulated/preserved blood set likelihood coagulation precipitated calcium content lactated ringer \u2019 injection , usp . dosing information choice product , , volume , rate , duration dependent upon age , weight condition patient concomitant therapy , determined physician experienced intravenous fluid therapy . introduction additives additives may incompatible . evaluate additions plastic container compatibility stability resulting preparation . consult pharmacist , available . ceftriaxone known incompatible lactated ringer \u2019 injection , usp due precipitate formation . ceftriaxone must mixed lactated ringer \u2019 injection , usp . , informed judgment physician , deemed advisable introduce additives , aseptic technique . mix thoroughly additives introduced . addition , discoloration and/or appearance precipitates , insoluble complexes crystals , . store solutions containing additives . content immediately opening container . discard unused portion .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "lactated ringer \u2019 injection , usp viaflex plastic container available follows : code size ( ml ) ndc 2b2322 250 0338-0117-02 2b2323 500 0338-0117-03 2b2324 1000 0338-0117-04 exposure pharmaceutical products heat minimized . avoid excessive heat . recommended product stored room temperature ( 25\u00b0c ) ; brief exposure 40\u00b0c adversely affect product .",
    "adverseReactions": "lactated ringer \u2019 injection , usp contraindicated : \u2022newborns ( \u226428 days age ) receiving concomitant treatment ceftriaxone , even separate infusion lines used due risk fatal ceftriaxone-calcium salt precipitation neonate \u2019 bloodstream . \u2022patients older 28 days , including adults , administered ceftriaxone simultaneously infusion line ( e.g . , via y-connector ) . infusion line used sequential , line must thoroughly flushed infusions compatible fluid . \u2022patients known hypersensitivity sodium lactate ( ) .",
    "indications_original": "Lactated Ringer\u2019s Injection, USP is indicated as a source of water and electrolytes or as an alkalinizing agent.",
    "contraindications_original": "Important Preparation and Administration Instructions \n                  \n                  \n                     \n                        \u2022Lactated Ringer\u2019s Injection, USP is intended for intravenous administration using sterile equipment. \n                     \n                        \u2022Prior to infusion, visually inspect the solution for particulate matter and discoloration. The solution should be clear, and there should be no precipitates. Do not administer unless solution is clear, and container is undamaged.\n                     \n                        \u2022To reduce the risk of air embolism, adhere to the following preparation instructions for Lactated Ringer\u2019s Injection, USP:\n                     \n                        oUse a non-vented infusion set or close the vent on a vented set.\n                     \n                        oUse a dedicated line without any connections (do not connect flexible containers in series).\n                     \n                        oThe use of pressure infusion is not recommended as a method to increase flow rates.  However, if pressure infusion is required, ensure that any air within the bag is fully evacuated prior to initiation of infusion.\n                     \n                        oIf using a pumping device to administer Lactated Ringer\u2019s Injection, turn off the pump before the container is empty.\n                     \n                     \n                        \u2022Do not administer Lactated Ringer\u2019s Injection, USP simultaneously with citrate anticoagulated/preserved blood through the same administration set because of the likelihood of coagulation precipitated by the calcium content of Lactated Ringer\u2019s Injection, USP.\n                  \n                  \n                     Dosing Information\n                  \n                  The choice of product, dosage, volume, rate, and duration of administration is dependent upon the age, weight and clinical condition of the patient and concomitant therapy, and administration should be determined by a physician experienced in intravenous fluid therapy.\n                  \n                     Introduction of Additives \n                  \n                  Additives may be incompatible. \n                  Evaluate all additions to the plastic container for compatibility and stability of the resulting preparation. Consult with a pharmacist, if available. \n                  Ceftriaxone is known to be incompatible with Lactated Ringer\u2019s Injection, USP due to precipitate formation. Ceftriaxone must not be mixed with Lactated Ringer\u2019s Injection, USP.  If, in the informed judgment of the physician, it is deemed advisable to introduce additives, use aseptic technique. Mix thoroughly when additives have been introduced. After addition, if there is a discoloration and/or the appearance of precipitates, insoluble complexes or crystals, do not use. Do not store solutions containing additives. Use content immediately after opening the container. Discard any unused portion.",
    "warningsAndPrecautions_original": "Lactated Ringer\u2019s Injection, USP in VIAFLEX plastic container is available as follows:\n                  \n                     \n                     \n                     \n                     \n                        \n                           \n                              \n                                 Code\n                              \n                           \n                           \n                              \n                                 Size (mL)\n                              \n                           \n                           \n                              \n                                 NDC\n                              \n                           \n                        \n                        \n                           \n                               2B2322 \n                           \n                           \n                               250 \n                           \n                           \n                               0338-0117-02 \n                           \n                        \n                        \n                           \n                               2B2323 \n                           \n                           \n                               500 \n                           \n                           \n                               0338-0117-03 \n                           \n                        \n                        \n                           \n                               2B2324 \n                           \n                           \n                               1000 \n                           \n                           \n                               0338-0117-04 \n                           \n                        \n                     \n                  \n                  Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. It is recommended the product be stored at room temperature (25\u00b0C); brief exposure up to 40\u00b0C does not adversely affect the product.",
    "adverseReactions_original": "Lactated Ringer\u2019s Injection, USP is contraindicated in:\n                  \n                     \n                        \u2022Newborns (\u226428 days of age) receiving concomitant treatment with ceftriaxone, even if separate infusion lines are used due to the risk of fatal ceftriaxone-calcium salt precipitation in the neonate\u2019s bloodstream.\n                     \n                        \u2022Patients older than 28 days, including adults, administered ceftriaxone simultaneously through the same infusion line (e.g., via a Y-connector). If the same infusion line is used for sequential administration, the line must be thoroughly flushed between infusions with a compatible fluid.\n                     \n                        \u2022Patients with known hypersensitivity to sodium lactate (see WARNINGS\n                        ).",
    "drug": [
        {
            "name": "Lactated Ringers",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_26710"
        }
    ]
}